BackSAB Biotherapeutics- Warrants (25/07/2027) Overview

SAB Biotherapeutics- Warrants (25/07/2027) Current Assets

Latest current assets for SABSW: $110M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$107.94M
↑ 1059.60% YoYΔ $98.63M vs prior year quarter

Peer trimmed avg / median

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Current Assets History

Loading

SAB Biotherapeutics- Warrants (25/07/2027) vs. peers: Current Assets Comparison

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) FAQ

As of the most recent data (June 2026), SABSW shows a current assets of $110M. That compares with $9.3M in the prior-year period — up 1059.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SABSW's current assets is now $110M (was $9.3M) — a 1059.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SAB Biotherapeutics- Warrants (25/07/2027) is outperforming or lagging.

Tracking SABSW's current assets over time shows whether SAB Biotherapeutics- Warrants (25/07/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $9.3M in the prior-year period — up 1059.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has SAB Biotherapeutics- Warrants (25/07/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $110M) with ownership activity and broader fundamentals.